Literature DB >> 7045549

Evaluation of aldosterone antagonists in healthy man.

G T McInnes, J R Shelton, L E Ramsay.   

Abstract

The development of methods to allow the quantitative comparison of aldosterone antagonists in healthy men is reviewed. Pharmacological action is measured against a background of mineralocorticoid excess, induced either by administration of exogenous mineralocorticoid (usually aldosterone or fludrocortisone), or by stimulation of endogenous mineralocorticoid using salt restriction, diuretic administration, or a combination of the two. Use of fludrocortisone as the exogenous mineralocorticoid has proved convenient and useful, but the influence of aldosterone antagonists on potassium metabolism has proved somewhat inconstant in this experimental model. Repeated administration of a medium-potency diuretic appears to provide a clinically relevant situation in which the effect of aldosterone antagonists on potassium metabolism can be assessed. We describe these experimental methods in detail, discuss their applications, and make some suggestions for further research.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7045549

Source DB:  PubMed          Journal:  Methods Find Exp Clin Pharmacol        ISSN: 0379-0355


  2 in total

1.  Clinical safety, tolerability, pharmacokinetics and effects on urinary electrolyte excretion of AZD9977, a novel, selective mineralocorticoid receptor modulator.

Authors:  Fredrik Erlandsson; Muna Albayaty; Ligia Chialda; Hans Ericsson; Carl Amilon; Karin Nelander; Rasmus Jansson-Löfmark; Linda Wernevik; Magnus Kjaer; Krister Bamberg; Judith Hartleib-Geschwindner
Journal:  Br J Clin Pharmacol       Date:  2018-04-22       Impact factor: 4.335

2.  Assessment of the antimineralocorticoid effect of RU 28318 in healthy men with induced exogenous and endogenous hypermineralocorticism.

Authors:  A Ulmann; C Bertagna; A Le Go; J M Husson; A Tache; P Sassano; J Menard; P Corvol
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.